Kreeftmeijer, J: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium

Annemarie R Kreeftmeijer-Vegter, Perry J van Genderen, Leo G Visser…

Journal:

Malaria Journal

Year:

2012

Language:

english

File:

PDF, 286 KB

english, 2012

2

Roll out of intraveneous artesunate under named patient programmes in the Netherlands, Belgium and France

Kreeftmeijer-Vegter, Annemarie, van Veldhuizen, Cornelis KW, de Vries, Peter J

Journal:

Orphanet Journal of Rare Diseases

Year:

2013

Language:

english

File:

PDF, 471 KB

english, 2013

3

The influence of the European paediatric regulation on marketing authorisation of orphan drugs for children

Annemarie Rosan Kreeftmeijer-Vegter,Anthonius de Boer…

Journal:

Orphanet Journal of Rare Diseases

Year:

2014

Language:

english

File:

PDF, 664 KB

english, 2014

4

Manual blood exchange transfusion does not significantly contribute to parasite clearance in artesunate-treated individuals with imported severePlasmodium falciparummalaria

Annemarie R Kreeftmeijer-Vegter, Mariana de Mendonça Melo…

Journal:

Malaria Journal

Year:

2013

Language:

english

File:

PDF, 333 KB

english, 2013

5

Genomic and transcriptomic plasticity in treatment-naive ovarian cancer

Hoogstraat, M., de Pagter, M. S., Cirkel, G. A., van Roosmalen, M. J., Harkins, T. T., Duran, K., Kreeftmeijer, J., Renkens, I., Witteveen, P. O., Lee, C. C., Nijman, I. J., Guy, T., van 't Slot, R.,

Journal:

Genome Research

Year:

2014

Language:

english

File:

PDF, 1.06 MB

english, 2014

6

Development and evaluation of age-appropriate film-coated tablets of levamisole for paediatric use (2 – 18 years)

Kreeftmeijer-Vegter, Annemarie Rosan, de Meijer, Mariska, Wegman, Kim AM, van Veldhuizen, Cees KW

Journal:

Expert Opinion on Drug Delivery

Year:

2013

Language:

english

File:

PDF, 459 KB

english, 2013

7

Decision Drivers For Brazil: An Analysis of Conitec Recommendations

Kreeftmeijer, J., Skaltsa, K., Palazzolo, D.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 63 KB

english, 2014

8

Prevalence-Based Measurement of the Economic Burden of Rare Diseases: Case Review To Determine the Annual Cost of Acromegaly In Italy

Tasdemir, E., Magestro, M., Griner, B.P., Cummins, G., Van, Engen A., Kreeftmeijer, J., Niemira, J., Tao, C.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 63 KB

english, 2014

9

Prevalence-Based Measurement of the Economic Burden of Rare Diseases: Case Review To Determine the Annual Cost of Acromegaly In France

Tasdemir, E., Magestro, M., Griner, B.P., Cummins, G., Van, Engen A., Kreeftmeijer, J., Niemira, J., Tao, C.

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 62 KB

english, 2014

10

Population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndrome

Kreeftmeijer-Vegter, A. R., Dorlo, T. P. C., Gruppen, M. P., de Boer, A., de Vries, P. J.

Journal:

British Journal of Clinical Pharmacology

Year:

2015

Language:

english

File:

PDF, 914 KB

english, 2015

11

Decision Drivers in Health Technology Assessment in Hepatitis C

Kool-Houweling, LM, Kreeftmeijer, J, Van Engen, A

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 65 KB

english, 2015

12

To What Extent Do Payers’ Assessment Of Clinically Relevant Outcomes Align With Clinicians In Oncology?

Ryan, J, van Engen, A, Heemstra, L, Kreeftmeijer, J

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 48 KB

english, 2015

13

Hierarchy of clinical endpoints in HTA decision making in Oncology

Kreeftmeijer, J., Ryan, J., Van Engen, A., Heemstra, L.

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 49 KB

english, 2015

14

Impact of tolerability profiles on HTA decision making in Oncology

Kreeftmeijer, J., Ryan, J., Van Engen, A., Heemstra, L.

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 49 KB

english, 2015

15

Drivers in HTA Decision-Making for Cholesterol Lowering PCSK9 Inhibitors

Kreeftmeijer, J, Dekkers, R, van Engen, A

Journal:

Value in Health

Year:

2016

Language:

english

File:

PDF, 61 KB

english, 2016

16

Market Access Pathways for Drugs with EMA Conditional Approval

Lie, X, Kreeftmeijer, J, Bossers, N, Haigh, J

Journal:

Value in Health

Year:

2016

Language:

english

File:

PDF, 71 KB

english, 2016

17

Nice Collateral Effect: What Is The Influence Of Nice On Other Hta Bodies?

Wijnands, T, Kreeftmeijer, J, Kooreman, PJ, Wagner, P, van Engen, A

Journal:

Value in Health

Year:

2016

Language:

english

File:

PDF, 57 KB

english, 2016

18

The Fundamental Characteristics of a Translational Scientist

Gilliland, C. Taylor, White, Julia, Gee, Barry, Kreeftmeijer-Vegter, Rosan, Bietrix, Florence, Ussi, Anton E., Hajduch, Marian, Kocis, Petr, Chiba, Nobuyoshi, Hirasawa, Ryutaro, Suematsu, Makoto, Brya

Journal:

ACS Pharmacology & Translational Science

Year:

2019

Language:

english

File:

PDF, 1.63 MB

english, 2019

19

The Fundamental Characteristics of a Translational Scientist

Gilliland, C. Taylor, White, Julia, Gee, Barry, Kreeftmeijer-Vegter, Rosan, Bietrix, Florence, Ussi, Anton E., Hajduch, Marian, Kocis, Petr, Chiba, Nobuyoshi, Hirasawa, Ryutaro, Suematsu, Makoto, Brya

Journal:

ACS Pharmacology & Translational Science

Year:

2019

File:

PDF, 1.63 MB

2019